Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
Abstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological inform...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-021-06312-3 |
id |
doaj-76db6b4eb595495eb18e8e295ce3908b |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhen Wang Bin Zhao Minghui An Wei Song Xue Dong Xin Li Lu Wang Lin Wang Wen Tian Haibo Ding Xiaoxu Han |
spellingShingle |
Zhen Wang Bin Zhao Minghui An Wei Song Xue Dong Xin Li Lu Wang Lin Wang Wen Tian Haibo Ding Xiaoxu Han Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 BMC Infectious Diseases HIV-1 Pre-exposure prophylaxis Transmitted drug resistance |
author_facet |
Zhen Wang Bin Zhao Minghui An Wei Song Xue Dong Xin Li Lu Wang Lin Wang Wen Tian Haibo Ding Xiaoxu Han |
author_sort |
Zhen Wang |
title |
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 |
title_short |
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 |
title_full |
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 |
title_fullStr |
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 |
title_full_unstemmed |
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018 |
title_sort |
transmitted drug resistance to tenofovir/emtricitabine among persons with newly diagnosed hiv infection in shenyang city, northeast china from 2016 to 2018 |
publisher |
BMC |
series |
BMC Infectious Diseases |
issn |
1471-2334 |
publishDate |
2021-07-01 |
description |
Abstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological information of all newly diagnosed HIV-1 infected residents in Shenyang city from 2016 to 2018 were anonymously collected from the local HIV epidemic database. HIV-1 pol sequences were amplified from RNA in cryopreserved plasma samples and sequenced directly. Viral subtypes were inferred with phylogenetic analysis and drug resistance mutations (DRMs) were determined according to the Stanford HIVdb algorithm. Recent HIV infection was determined with HIV Limiting Antigen avidity electro immunoassay. Results A total of 2176 sequences (92.4%, 2176/2354) were obtained; 70.9% (1536/2167) were CRF01_AE, followed by CRF07_BC (18.0%, 391/2167), subtype B (4.7%, 102/2167), other subtypes (2.6%, 56/2167), and unique recombinant forms (3.8%, 82/2167). The prevalence of TDR was 4.9% (107/2167), among which, only 0.6% (13/2167) was resistance to TDF/FTC. Most of these subjects had CRF01_AE strains (76.9%, 10/13), were unmarried (76.9%, 10/13), infected through homosexual contact (92.3%, 12/13), and over 30 years old (median age: 33). The TDF/FTC DRMs included K65R (8/13), M184I/V (5/13), and Y115F (2/13). Recent HIV infection accounted for only 23.1% (3/13). Most cases were sporadic in the phylogenetic tree, except two CRF01_AE sequences with K65R (Bootstrap value: 99%). Conclusions The prevalence of TDR to TDF/FTC is low among newly diagnosed HIV-infected cases in Shenyang, suggesting that TDR may have little impact on the protective effect of the ongoing CROPrEP project in Shenyang city. |
topic |
HIV-1 Pre-exposure prophylaxis Transmitted drug resistance |
url |
https://doi.org/10.1186/s12879-021-06312-3 |
work_keys_str_mv |
AT zhenwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT binzhao transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT minghuian transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT weisong transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT xuedong transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT xinli transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT luwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT linwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT wentian transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT haiboding transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 AT xiaoxuhan transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018 |
_version_ |
1721308577612693504 |
spelling |
doaj-76db6b4eb595495eb18e8e295ce3908b2021-07-11T11:51:48ZengBMCBMC Infectious Diseases1471-23342021-07-012111610.1186/s12879-021-06312-3Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018Zhen Wang0Bin Zhao1Minghui An2Wei Song3Xue Dong4Xin Li5Lu Wang6Lin Wang7Wen Tian8Haibo Ding9Xiaoxu Han10National Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)National Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityAbstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological information of all newly diagnosed HIV-1 infected residents in Shenyang city from 2016 to 2018 were anonymously collected from the local HIV epidemic database. HIV-1 pol sequences were amplified from RNA in cryopreserved plasma samples and sequenced directly. Viral subtypes were inferred with phylogenetic analysis and drug resistance mutations (DRMs) were determined according to the Stanford HIVdb algorithm. Recent HIV infection was determined with HIV Limiting Antigen avidity electro immunoassay. Results A total of 2176 sequences (92.4%, 2176/2354) were obtained; 70.9% (1536/2167) were CRF01_AE, followed by CRF07_BC (18.0%, 391/2167), subtype B (4.7%, 102/2167), other subtypes (2.6%, 56/2167), and unique recombinant forms (3.8%, 82/2167). The prevalence of TDR was 4.9% (107/2167), among which, only 0.6% (13/2167) was resistance to TDF/FTC. Most of these subjects had CRF01_AE strains (76.9%, 10/13), were unmarried (76.9%, 10/13), infected through homosexual contact (92.3%, 12/13), and over 30 years old (median age: 33). The TDF/FTC DRMs included K65R (8/13), M184I/V (5/13), and Y115F (2/13). Recent HIV infection accounted for only 23.1% (3/13). Most cases were sporadic in the phylogenetic tree, except two CRF01_AE sequences with K65R (Bootstrap value: 99%). Conclusions The prevalence of TDR to TDF/FTC is low among newly diagnosed HIV-infected cases in Shenyang, suggesting that TDR may have little impact on the protective effect of the ongoing CROPrEP project in Shenyang city.https://doi.org/10.1186/s12879-021-06312-3HIV-1Pre-exposure prophylaxisTransmitted drug resistance |